Rheopheresis for dry AMD: Controversy requiring mutual respect [2]

Journal of Clinical Apheresis

Volumn 20, Issue 3, 2005, Pages 169-170

  Klingel, Reinhard ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Apheresis Research Institute   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; GERMANY; HIGH RISK PATIENT; HUMAN; LETTER; PATIENT SELECTION; PLASMAPHERESIS; REGISTER; RETINA MACULA AGE RELATED DEGENERATION; RHEOPHERESIS; SAFETY; TREATMENT INDICATION; UNITED STATES;

BLOOD COMPONENT REMOVAL; HUMANS; MACULAR DEGENERATION; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 30544448197     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20067     Document Type: Letter

References (8)

1. Klingel R, Fassbender C, Fassbender T, Göhlen B. Clinical studies to implement rheopheresis for age-related macular degeneration guided by evidence-based medicine. Transfus Apheresis Sci 2003;29:71-84.
2. Pulido JS, Sanders D, Klingel R. Rheopheresis for age-related macular degeneration: clinical results and putative mechanism of action. Can J Ophthalmol 2005;40:332-340.
3. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005;102:7227-7232.
4. Multicenter Investigation of Rheopheresis for AMD (MIRA-1) Study Group Writing Committee. Pulido J, Klingel R, Sanders DR. Multicenter prospective randomized double-masked placebo controlled study of rheopheresis to treat dry AMD: interim analysis. Trans Am Ophthalmol Soc 2002;100:85-108.
5. Brunner R, Widder RA, Walter P, Luke C, Godehardt E, Bartz-Schmidt K-U, Heimann K, Borberg H. Influence of membrane differential filtration on the natural course of age-related macular degeneration: a randomized trial. Retina 2000; 20:483-491.
6. Swartz M, Rabetoy G. Treatment of non-exudative age-related macular degeneration using membrane differential filtration apheresis. Invest Ophthalmol Vis Sci 1999;40:319 (abstract).
7. Klingel R, Wong D, Fassbender C, Siegel I, Erdtracht B. Safety and efficacy of Rheopheresis for age-related macular degeneration (AMD): reference controlled RheoNet-registry analysis. Inv Ophthalmol Vis Sci 2005;46:E-2368 (abstract).
8. McGwin G Jr, Xie A, Owsley C. The use of cholesterol-lowering medications and age-related macular degeneration. Ophthalmology 2005;112:488-494.